Commercial-News (Danville, Illinois; June 21) – “My current study tests the feasibility of a standardized protocol for high-flow nasal oxygen therapy (HFNOT),” explains Dr. Reinhart. “This won’t prove definitively that high-flow is needed or better for patients with blastomycosis. Instead, the data we collect will help us design a larger study to examine whether patients benefit from starting HFNOT right away.”
Also in:
* News-Gazette (July 6)
https://www.news-gazette.com/living/pets/pet-talk-seeking-better-treatment-for-blastomycosis/article_0c570643-2576-4ff6-8713-639e11e4f940.html